Olestra vs High-Fructose Corn Syrup: which is worse?

What is Olestra?

Olestra (brand name Olean) is a synthetic fat substitute made from sucrose and fatty acids. Unlike regular fats, olestra is not absorbed by the digestive system — it passes through the body unchanged, providing zero calories while mimicking fat's texture and taste in food. It was developed by Procter & Gamble and FDA-approved in 1996.

What is High-Fructose Corn Syrup?

High-fructose corn syrup (HFCS) is a liquid sweetener produced by enzymatically converting a portion of corn syrup's glucose to fructose. The most common forms are HFCS-55 (55% fructose, 45% glucose, used primarily in beverages) and HFCS-42 (42% fructose, used in processed foods). It became dominant in the US food supply in the 1970s-1980s.

Documented risks

Olestra: Olestra caused significant gastrointestinal side effects that were prominently noted on mandatory warning labels: 'This Product Contains Olestra. Olestra may cause abdominal cramping and loose stools. Olestra inhibits the absorption of some vitamins and other nutrients. Vitamins A, D, E, and K have been added.' Reported gastrointestinal effects included diarrhea, abdominal cramping, oily anal leakage ('anal leakage' or 'rectal leakage'), and fatty stools. These effects were often embarrassing and uncomfortable. Multiple consumer complaints documented GI distress from Olean chips. Beyond GI effects, olestra significantly inhibits the absorption of fat-soluble vitamins (A, D, E, K) and fat-soluble carotenoids (lycopene, lutein, beta-carotene). Since fat-soluble vitamins require fat for absorption, and olestra passes through without being absorbed, it 'captures' these vitamins and carries them out of the body. Studies found olestra consumption reduced serum carotenoid levels, prompting Frito-Lay to fortify olestra products with fat-soluble vitamins to compensate. The FDA removed the mandatory GI warning requirement in 2003 after Frito-Lay argued the warning was overstated, though olestra's use had already declined dramatically due to consumer avoidance.

High-Fructose Corn Syrup: HFCS has been at the center of one of nutrition science's most contentious debates for 30+ years. The core concern is that fructose is metabolized differently than glucose: fructose is processed primarily in the liver where it can be converted to fat (de novo lipogenesis), contributing to non-alcoholic fatty liver disease (NAFLD) and elevated triglycerides. A landmark 2004 paper by Bray, Nielsen, and Popkin in the American Journal of Clinical Nutrition proposed that the increase in HFCS consumption from the 1970s tracked with rising obesity rates. This hypothesis was widely publicized but contested; subsequent controlled research found that HFCS and sucrose produce similar metabolic effects calorie-for-calorie. However, the broader research on fructose metabolism supports metabolic concerns. A 2012 PLOS ONE study (Basu et al.) found higher sugar-sweetened beverage consumption associated with increased rates of metabolic syndrome and type 2 diabetes. A 2012 Nature commentary by Lustig, Schmidt, and Brindis ('The Toxic Truth About Sugar') argued fructose's hepatic metabolism makes it uniquely harmful — prompting significant scientific debate. Key established effects of high fructose intake include: increased visceral fat, elevated blood triglycerides, increased uric acid (gout risk), worsened insulin resistance, and accelerated NAFLD progression. These effects occur with high fructose intake from any source (HFCS or sucrose), making HFCS no inherently worse than sucrose at equivalent doses — but its ubiquity in US processed foods contributes to chronically elevated fructose exposure at a population level. Mercury contamination: in 2009, independent testing by the Institute for Agriculture and Trade Policy (IATP) and a study in Environmental Health found mercury traces in some HFCS samples from certain manufacturers using mercury-grade caustic soda. The industry has largely transitioned to mercury-free processing since these findings.